The Epigenetic Echo: How Early Life Adversity Rewrites the Biological Blueprint
New research from a collaborative team at Arizona State University and Vanderbilt University has fundamentally shifted our understanding of how...
New research from a collaborative team at Arizona State University and Vanderbilt University has fundamentally shifted our understanding of how...
Executive Summary: A New Paradigm in Analytical Precision In a move set to redefine the landscape of biopharmaceutical analytical workflows,...
The manufacturing of Advanced Therapy Medicinal Products (ATMPs)—including gene therapies and cell-based treatments—has long been hampered by the limitations of...
A pioneering study led by researchers at the Children’s Hospital of Philadelphia (CHOP) has unveiled a transformative approach to treating...
In the high-stakes environment of biopharmaceutical manufacturing, the pursuit of perfection is often a zero-sum game. When purifying complex biologics,...
Pancreatic ductal adenocarcinoma (PDAC) stands as one of the most formidable challenges in modern oncology. Characterized by late-stage diagnosis, aggressive...
In a significant move to reshape the future of biologics, pharmaceutical giant Merck & Co. has entered into a multi-target...
In a watershed moment for the life sciences sector, Cambridge-based Parabilis Medicines (Nasdaq: PBLS) has officially cemented its position at...
For over half a century, the scientific understanding of collagen—the most abundant protein in the human body—has been governed by...
Duchenne muscular dystrophy (DMD), a devastating genetic condition characterized by progressive muscle degeneration, has long remained a "holy grail" for...
In a landmark study that challenges the conventional wisdom surrounding substance use disorders, researchers at the University of California San...
For structural biologists, the challenge of visualizing the molecular machinery of life has long been akin to trying to read...